Regeneron Pharmaceuticals, Inc. (LON:0R2M)

Regeneron Pharmaceuticals Statistics

Total Valuation

LON:0R2M has a market cap or net worth of GBP 55.45 billion. The enterprise value is 43.67 billion.

Market Cap	55.45B
Enterprise Value	43.67B

Important Dates

The last earnings date was Friday, January 30, 2026.

Earnings Date	Jan 30, 2026
Ex-Dividend Date	Nov 20, 2025

Share Statistics

Current Share Class	100.78M
Shares Outstanding	n/a
Shares Change (YoY)	-5.65%
Shares Change (QoQ)	+0.28%
Owned by Insiders (%)	3.80%
Owned by Institutions (%)	87.13%
Float	98.52M

Valuation Ratios

The trailing PE ratio is 16.57 and the forward PE ratio is 15.52.

PE Ratio	16.57
Forward PE	15.52
PS Ratio	5.20
PB Ratio	2.39
P/TBV Ratio	2.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	13.05
EV / Sales	4.18
EV / EBITDA	14.07
EV / EBIT	16.07
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.77, with a Debt / Equity ratio of 0.09.

Current Ratio	4.77
Quick Ratio	4.22
Debt / Equity	0.09
Debt / EBITDA	0.64
Debt / FCF	n/a
Interest Coverage	85.11

Financial Efficiency

Return on equity (ROE) is 14.87% and return on invested capital (ROIC) is 15.93%.

Return on Equity (ROE)	14.87%
Return on Assets (ROA)	5.95%
Return on Invested Capital (ROIC)	15.93%
Return on Capital Employed (ROCE)	10.74%
Weighted Average Cost of Capital (WACC)	6.21%
Revenue Per Employee	700,090
Profits Per Employee	219,888
Employee Count	15,222
Asset Turnover	0.37
Inventory Turnover	2.53

Taxes

In the past 12 months, LON:0R2M has paid 539.27 million in taxes.

Income Tax	539.27M
Effective Tax Rate	13.88%

Stock Price Statistics

The stock price has increased by +8.45% in the last 52 weeks. The beta is 0.39, so LON:0R2M's price volatility has been lower than the market average.

Beta (5Y)	0.39
52-Week Price Change	+8.45%
50-Day Moving Average	753.63
200-Day Moving Average	617.41
Relative Strength Index (RSI)	45.99
Average Volume (20 Days)	704

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.36

Income Statement

In the last 12 months, LON:0R2M had revenue of GBP 10.66 billion and earned 3.35 billion in profits. Earnings per share was 30.82.

Revenue	10.66B
Gross Profit	4.75B
Operating Income	2.77B
Pretax Income	3.89B
Net Income	3.35B
EBITDA	3.16B
EBIT	2.77B
Earnings Per Share (EPS)	30.82

Balance Sheet

The company has 14.02 billion in cash and 2.01 billion in debt, with a net cash position of 12.01 billion.

Cash & Cash Equivalents	14.02B
Total Debt	2.01B
Net Cash	12.01B
Net Cash Per Share	n/a
Equity (Book Value)	23.22B
Book Value Per Share	225.69
Working Capital	16.33B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 44.57%, with operating and profit margins of 25.99% and 31.41%.

Gross Margin	44.57%
Operating Margin	25.99%
Pretax Margin	36.47%
Profit Margin	31.41%
EBITDA Margin	29.70%
EBIT Margin	25.99%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 2.68, which amounts to a dividend yield of 0.36%.

Dividend Per Share	2.68
Dividend Yield	0.36%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	5.65%
Shareholder Yield	6.01%
Earnings Yield	6.04%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3